Medications used by the 50 patients at the time of the study.
| Medication | No. Patients (%) |
|---|---|
| Methotrexate | 28 (56) |
| Hydroxychloroquine | 14 (28) |
| Sulfasalazine | 6 (12) |
| Azathioprine | 9 (18) |
| Cyclosporine A | 1 (2) |
| Leflunomide | 12 (24) |
| Sodium aurothiomalate | 1 (2) |
| Biologic agents | 45 (90) |
| Tumor necrosis factor-α antagonists | |
| Etanercept | 23 (46) |
| Infliximab | 9 (18) |
| Adalimumab | 12 (24) |
| Anakinra | 1 (2) |
| Glucocorticoids | 26 (52)* |
| Thalidomide | 1 (2) |
↵* Four patients (8%) on daily regimen, others on alternate-day regimen.